Probiotics to prevent cognitive dysfunction
Summary
USPTO granted patent US12593863B2 to INTERNATIONAL N&H DENMARK APS covering the use of Lacticaseibacillus paracasei bacteria for preventing or treating cognitive impairments, including those induced by sleep deprivation. The patent names Sile Griffin, Elaine Patterson, and Markus Lehtinen as inventors and includes 5 claims.
What changed
USPTO issued Patent Grant US12593863B2 (Kind B2) on April 7, 2026, covering bacteria of the species Lacticaseibacillus paracasei for preventing or treating cognitive impairments in subjects. The patent also extends to cognitive impairments induced by sleep deprivation and/or insufficient sleep. Assignee is INTERNATIONAL N&H DENMARK APS, with a filing date of October 8, 2021, and Application No. 18248077.
This patent grant establishes intellectual property protection for the probiotic composition and its method of use. No immediate compliance actions are required from industry participants. Competitors developing similar probiotic formulations for cognitive health should review this patent for potential licensing needs or design-around considerations.
Archived snapshot
Apr 7, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Probiotics to prevent cognitive dysfunction
Grant US12593863B2 Kind: B2 Apr 07, 2026
Assignee
INTERNATIONAL N&H DENMARK APS
Inventors
Sile Griffin, Elaine Patterson, Markus Lehtinen
Abstract
This invention relates to bacteria of the species Lacticaseibacillus paracasei for use in preventing or treating cognitive impairments in a subject in need thereof. This invention also relates to bacteria of the species Lacticaseibacillus paracasei for use in preventing or treating cognitive impairments induced by sleep deprivation and/or insufficient sleep in a subject in need thereof.
CPC Classifications
A23L 33/135 A61P 25/28 A61K 2035/115
Filing Date
2021-10-08
Application No.
18248077
Claims
5
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.